Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelActive TiUltra 3.0 3.0x11.5mm: medical device reports filed with FDA

1,310 reports name it, 2020–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

1,310
device reports naming the brand
0% of all MAUDE reports · about 235 a year
286
reports, 12 months to August 2026
300 in the 12 months before
1.5%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,310 reports that name the brand "NobelActive TiUltra 3.0 3.0x11.5mm" (endosseous dental implant), received between December 2020 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

286 reports arrived in the 12 months to August 2026, close to the 300 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.5%) and malfunction (1.5%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (74%), loss of osseointegration (8.9%) and osseointegration problem (8.2%). The patient problems coded most often are failure of implant, pain and abscess. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04794Sep 2021: 6Oct 2021: 6Nov 2021: 22Dec 2021: 182022Jan 2022: 22Feb 2022: 13Mar 2022: 31Apr 2022: 14May 2022: 16Jun 2022: 16Jul 2022: 22Aug 2022: 10Sep 2022: 8Oct 2022: 14Nov 2022: 22Dec 2022: 182023Jan 2023: 18Feb 2023: 22Mar 2023: 18Apr 2023: 26May 2023: 14Jun 2023: 26Jul 2023: 24Aug 2023: 18Sep 2023: 14Oct 2023: 24Nov 2023: 16Dec 2023: 62024Jan 2024: 12Feb 2024: 24Mar 2024: 18Apr 2024: 36May 2024: 22Jun 2024: 20Jul 2024: 22Aug 2024: 14Sep 2024: 18Oct 2024: 24Nov 2024: 24Dec 2024: 122025Jan 2025: 26Feb 2025: 38Mar 2025: 20Apr 2025: 10May 2025: 0Jun 2025: 0Jul 2025: 94Aug 2025: 34Sep 2025: 30Oct 2025: 26Nov 2025: 14Dec 2025: 182026Jan 2026: 28Feb 2026: 12Mar 2026: 26Apr 2026: 32May 2026: 16Jun 2026: 36Jul 2026: 30Aug 2026: 18

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01553102020: 620202021: 11820212022: 20620222023: 22620232024: 24620242025: 31020252026: 1982026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.5%1,291
Malfunction1.5%19
Other0%0
Not given0%0

Who filed the report

Manufacturer report50.1%656
Voluntary report0%0
User facility report0%0
Distributor report49.9%654
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate97074%62.8%
Loss of osseointegration1168.9%22.4%
Osseointegration problem1088.2%7.7%
Patient device interaction problem221.7%0.3%
Insufficient device problem information141.1%0.2%
Activation, positioning or separation problem60.5%0%
Device markings/labelling problema problem with the device markings or label60.5%0%
Migrationthe device moved from where it was placed60.5%0.1%
Fracturea broken bone40.3%1.6%
Material deformation40.3%0.1%
Mechanical problema mechanical problem40.3%0.1%
Separation failure40.3%0.1%
Difficult to insertthe device was hard to insert20.2%0.4%
Malposition of device20.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant84064.1%
Painpain, site not specified826.3%
Abscessa collection of pus262%
Inflammationinflammation141.1%
Numbnessnumbness141.1%
Implant pain131%
Appropriate clinical signs, symptoms and conditions term/code not available80.6%
Bone fracture(s)80.6%
Fistula80.6%
Sinus perforation40.3%
Hypersensitivity/allergic reaction20.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelActive TiUltra 3.0 3.0x11.5mmProduct code DZEAll MAUDE reports
Reports1,3103,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.5%99.2%36.2%
Classified as malfunction1.5%0.8%62.3%
Filed by the manufacturer50.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelActive TiUltra 3.0 3.0x11.5mm reports

How many FDA reports name NobelActive TiUltra 3.0 3.0x11.5mm?

1,310 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 286 in the latest 12 months.

What kinds of events are reported?

injury (98.5%) and malfunction (1.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (74%), loss of osseointegration (8.9%), osseointegration problem (8.2%), patient device interaction problem (1.7%) and insufficient device problem information (1.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50.1%) and distributor reports (49.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelActive TiUltra 3.0 3.0x11.5mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.